Insight Molecular Diagnostics Inc.
General ticker "IMDX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $138.1M (TTM average)
Insight Molecular Diagnostics Inc. follows the US Stock Market performance with the rate: 41.2%.
Estimated limits based on current volatility of 5.9%: low 3.72$, high 4.19$
Factors to consider:
- Earnings expected soon, date: 2026-05-11 amc
- Total employees count: 9 as of 2015
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.43$, 10.06$]
- 2026-12-31 to 2027-12-31 estimated range: [2.41$, 7.37$]
Short-term IMDX quotes
Long-term IMDX plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $4.05MM |
| Operating Expenses | $34.63MM |
| Operating Income | $-30.58MM |
| Non-Operating Income | $-19.64MM |
| Interest Expense | $0.11MM |
| R&D Expense | $15.90MM |
| Income(Loss) | $-50.22MM |
| Profit(Loss)* | $-50.22MM |
| Stockholders Equity | $-31.46MM |
| Inventory | $0.45MM |
| Assets | $25.76MM |
| Operating Cash Flow | $-22.18MM |
| Capital expenditure | $3.19MM |
| Investing Cash Flow | $-3.19MM |
| Financing Cash Flow | $28.07MM |
| Earnings Per Share** | $-1.65 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.